The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations
Open accessAbstract
Human pluripotent stem cells (hPS cells) can self-renew indefinitely, making them an attractive source for regenerative therapies. This expansion potential has been linked with the acquisition of large copy number variants that provide mutated cells with a growth advantage in culture. The nature, extent and functional effects of other acquired genome sequence mutations in cultured hPS cells are not known. Here we sequence the protein-coding genes (exomes) of 140 independent human embryonic stem cell (hES cell) lines, including 26 lines prepared for potential clinical use. We then apply computational strategies for identifying mutations present in a subset of cells in each hES cell line. Although such mosaic mutations were generally rare, we identified five unrelated hES cell lines that carried six mutations in the TP53 gene that encodes the tumour suppressor P53. The TP53 mutations we observed are dominant negative and are the mutations most commonly seen in human cancers. We found that the TP53 mutant allelic fraction increased with passage number under standard culture conditions, suggesting that the P53 mutations confer selective advantage. We then mined published RNA sequencing data from 117 hPS cell lines, and observed another nine TP53 mutations, all resulting in coding changes in the DNA-binding domain of P53. In three lines, the allelic fraction exceeded 50%, suggesting additional selective advantage resulting from the loss of heterozygosity at the TP53 locus. As the acquisition and expansion of cancer-associated mutations in hPS cells may go unnoticed during most applications, we suggest that careful genetic characterization of hPS cells and their differentiated derivatives be carried out before clinical use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“and six specific variants in TP53 have been identified in several hPSC lines.165”
From Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes (2023) · cites this paper as [165]
In the citing paper
“For pluripotent stem cells—embryonic stem cells (ESCs) or induced pluripotent stem cells (iPSCs)—there appears to be a selection advantage for mutations of some oncogenes, in particular for TP53 and BCOR, which can become fixed in culture74,75.”
From How to design preclinical studies in nanomedicine and cell therapy to maximize the prospects of clinical translation (2018) · cites this paper as [74]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Robinson, J. T., Thorvaldsdóttir, H., Winckler, W., Guttman, M., Lander, E. S., Getz, G., & Mesirov, J. P. (2011) · Nature Biotechnology · doi:10.1038/nbt.1754 · Cited by 15,390
Kim, D., Pertea, G., Trapnell, C., Pimentel, H., Kelley, R., & Salzberg, S. L. (2013) · Genome Biology · doi:10.1186/gb-2013-14-4-r36 · Cited by 12,668
A framework for variation discovery and genotyping using next-generation DNA sequencing data
DePristo, M. A., Banks, E., Poplin, R. E., Garimella, K. V., Maguire, J., Hartl, C., Philippakis, A., del Angel, G., Rivas, M. A., Hanna, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.806 · Cited by 11,457
Analysis of protein-coding genetic variation in 60,706 humans
Exome Aggregation Consortium, Lek, M., Karczewski, K. J., Minikel, E. V., Samocha, K. E., Banks, E., Fennell, T., O’Donnell-Luria, A. H., Ware, J. S., Hill, A. J., et al. (2016) · Nature · doi:10.1038/nature19057 · Cited by 9,587
Self-citationdbSNP: the NCBI database of genetic variation
Sherry, S. T. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.1.308 · Cited by 7,502
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607 · cited 1×
“(15) not recoverable after thaw (3) unavailable (9)”
BackgroundAge-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841
Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence
Genovese, G., Kähler, A. K., Handsaker, R. E., Lindberg, J., Rose, S. A., Bakhoum, S. F., Chambert, K., Mick, E., Neale, B. M., Fromer, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409405 · Cited by 3,531
Self-citationHigh-throughput droplet digital PCR system for absolute quantitation of DNA copy number
Hindson, B. J., Ness, K. D., Masquelier, D. A., Belgrader, P., Heredia, N. J., Makarewicz, A. J., Bright, I. J., Lucero, M. Y., Hiddessen, A. L., Legler, T. C., et al. (2011) · Analytical Chemistry · doi:10.1021/ac202028g · Cited by 2,792
Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
Cho, Y., Gorina, S., Jeffrey, P. D., & Pavletich, N. P. (1994) · Science · doi:10.1126/science.8023157 · Cited by 2,559
Cited by
Sorted by citations
Items 401–500 of 505
Peng, D., Li, M., Yu, Z., Yan, T., Meng, Y., Su, L., Liu, Z. H., Li, L., & Qiu, H. (2024) · Cell Proliferation · doi:10.1111/cpr.13770 · Cited by 2
Chanock, S. J. (2017) · Nature · doi:10.1038/nature22490 · Cited by 2
Stem cell-based therapies threatened by the accumulation of p53 mutations
Baumann, K. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.52 · Cited by 2
A Multilevel Approach to the Causes of Genetic Instability in Stem Cells
González, E. A. P. (2022) · Springer eBooks · doi:10.1007/978-981-16-6016-0_26-1 · Cited by 2
Jiang, J., Qiu, T., Yang, C., Yuan, Y., Qin, L., & Zhang, P. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e11979 · Cited by 2
A Multilevel Approach to the Causes of Genetic Instability in Stem Cells
González, E. A. P. (2022) · Springer eBooks · doi:10.1007/978-981-19-2655-6_26 · Cited by 3
van den Brink, L., Grandela, C., Mummery, C. L., & Davis, R. P. (2019) · Cited by 2
Transcription Factor-Mediated Differentiation of Human iPSCs into Neurons v1Preprint
Fernandopulle, M. S., Prestil, R., Grunseich, C., Wang, C., Gan, L., & Ward, M. E. (2019) · doi:10.17504/protocols.io.54rg8v6 · Cited by 1
Kim, Y.-J., Kang, B., Kweon, S., Oh, S., Kim, D., Gil, D., Lee, H., Kim, J., Ju, J. H., Roh, T., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.17.572095 · Cited by 2
von Kügelgen, N., Vallone, V. B. F., Ludwik, K. A., Babaeva, M., Diecke, S., Beule, D., & Stachelscheid, H. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.01.691615 · Cited by 3
Daheron, L. M., & Chen, I. P.-F. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822277-5.00008-0 · Cited by 1
NSD3 protein methylation and stabilization transforms human ES cells into variant state
Krishnamoorthy, V. K., Hamdani, F., Shukla, P., Rao, R. A., Anaitullah, S., Biligiri, K. K., Kadumuri, R. V., Pothula, P. R., Chavali, S., & Rampalli, S. (2024) · Life Science Alliance · doi:10.26508/lsa.202402871 · Cited by 1
Aran, S., Golmohammadi, M. G., Sagha, M., & Ghaedi, K. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1498308 · Cited by 1
van Soest, M., Montilla‐Rojo, J., Eleveld, T. F., Looijenga, L. H. J., & Salvatori, D. C. F. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136464 · Cited by 1
Advances and optimization strategies in prime editing of human pluripotent stem cells
Getachew, H., Metais, T., Daheron, L. M., & Garita‐Hernandez, M. (2025) · Trends in biotechnology · doi:10.1016/j.tibtech.2025.06.017 · Cited by 1
Wen, X., Yao, G., Zhou, Y., Liu, S., & Sun, L. (2025) · Cellular Immunology · doi:10.1016/j.cellimm.2025.105046 · Cited by 1
Darden, C. M., Kuncha, J., Kirkland, J. T., MATTKE, J. D., Vasu, S., Saravanan, P. B., Naziruddin, B., & Lawrence, M. C. (2026) · Frontiers in Transplantation · doi:10.3389/frtra.2026.1740314 · Cited by 1
Safeguarding genomic integrity in pluripotent stem-cell therapies
Kong, S. W., Lee, I., Cha, Y., Carter, B., & Kim, K.-S. (2026) · The Lancet · doi:10.1016/s0140-6736(26)00095-4 · Cited by 1
Rossignoli, G., Oberhuemer, M., Brun, I. S., Zorzan, I., Osnato, A., Wenzel, A., van Genderen, E., Drusin, A., Panebianco, G., Magri, N., et al. (2026) · The EMBO Journal · doi:10.1038/s44318-026-00714-2 · Cited by 3
Thread- Reinforced Encapsulation Devices (THRED) for Therapeutic Stem Cell Delivery
Mesfin, F. M., Lee, J., Joseph, S., Manohar, K., Hunter, C. E., Shelley, W., Brokaw, J. P., Jiang, G., Liu, J.-Y., Gil, C.-H., et al. (2026) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2026.163196 · Cited by 1
Structure Variations and 3D Genome Disruption: Implications in Safety of hPSC-Based Cell Therapy
Li, M., Cui, F., Na, T., Ma, Q., Guo, M., Guo, M., Zhang, K., & Meng, S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27104573 · Cited by 1
Brulez, R., & Speeckaert, M. M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27135879 · Cited by 1
Modeling myeloid cell development in health and disease using induced pluripotent stem cells
Tesakov, I., Nasri, M., Klimiankou, M., Fındık, B., Loskill, P., & Skokowa, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1815809 · Cited by 1
Ho, T., & Lane, D. P. (2018) · The CRISPR Journal · doi:10.1089/crispr.2018.29021.dal · Cited by 1
Ubiquitin–Proteasome System in the Induction and Maintenance of Cellular Pluripotency
Zubarev, I. V., Podenkova, U. I., Tomilin, A. N., & Цимоха, А. С. (2022) · Russian Journal of Developmental Biology · doi:10.1134/s1062360422060091 · Cited by 1
Schulz, E. G. (2024) · Molecular Cell · doi:10.1016/j.molcel.2023.12.042 · Cited by 1
Genetic stability of hPSCs and considerations for cell therapy
Zanella, F., & Marcu, R. (2024) · Cell and Gene Therapy Insights · doi:10.18609/cgti.2024.023
Dysregulation of Immune Tolerance to Autologous iPSCs and Their Differentiated Derivatives
Bogomiakova, M. E., Bogomazova, A. N., & Lagarkova, M. A. (2024) · Biochemistry (Moscow) · doi:10.1134/s0006297924050031 · Cited by 1
Depletion of TP53 in Human Pluripotent Stem Cells Triggers Malignant‐Like Behavior
Montilla‐Rojo, J., Eleveld, T. F., van Soest, M., Hillenius, S., Timmerman, D. M., Gillis, A., Roelen, B. A. J., Mummery, C. L., Looijenga, L. H. J., & Salvatori, D. C. F. (2025) · Advanced Biology · doi:10.1002/adbi.202400538 · Cited by 1
The therapeutic potential of exogenous adult stem cells for the injured central nervous system
Smith, J. A., Braga, A., Hamel, R., Rutigliani, C., Yu, B., Peruzzotti‐Jametti, L., & Pluchino, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818084-6.00006-4 · Cited by 1
Human Embryonic Stem Cell Banking for Clinical Applications—20 Years from Their Isolation
Sousa, P. A. D. (2021) · Springer eBooks · doi:10.1007/978-3-030-71621-9_15 · Cited by 1
Genome-Scale CRISPR Screening Identifies Novel Human Pluripotent Gene NetworksPreprint
Ihry, R. J., Salick, M. R., Ho, D. J., Sondey, M., Kommineni, S., Paula, S., Raymond, J., Frias, E., Worringer, K. A., Russ, C., et al. (2018) · SSRN Electronic Journal · doi:10.2139/ssrn.3189387 · Cited by 1
TPX2 Amplification-Driven Aberrant Mitosis in Long-Term Cultured Human Embryonic Stem CellsPreprint
Jeong, H., Go, Y.-H., Shin, J., Kim, Y.-J., Cho, M.-G., Gwon, D., Cheong, H. S., Lee, H., Lee, J. H., Jang, C., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.22.432205 · Cited by 1
A Cultured Sensorimotor Organoid Model Forms Human Neuromuscular JunctionsPreprint
Pereira, J. D., DuBreuil, D. M., Devlin, A., Held, A., Sapir, Y., Berezovski, E., Hawrot, J., Dorfman, K., Chander, V., & Wainger, B. J. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.03.433128 · Cited by 1
From amputations to antibiotics: A future beyond “hacksaw” gene editing
Scott, T. A., & Morris, K. V. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.11.008 · Cited by 1
Lei, Y., Delbany, D. A., Krivec, N., Regin, M., de Deckersberg, E. C., Janssens, C., Ghosh, M. S., Sermon, K., & Spits, C. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.26.546513 · Cited by 1
[Leukocyte count of puerperal sows].
Mäde, D., & Wujanz, G. (1996) · PubMed
Cheaper and less variable expansion
Adil, M. M., & Schaffer, D. V. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0209-y
Stem cell therapy and regenerative medicine in RPE degenerative disease: advances and challenges
Takiuti, J. T., Takahashi, V. K. L., Apatoff, M. B. L., & Tsang, S. H. (2018) · Expert Review of Ophthalmology · doi:10.1080/17469899.2018.1555034
Delivery Methods for Treatment of Genetic Disorders
Gupta, K., & Selden, N. R. W. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813997-4.00022-0
Disease in a Dish: Cellular Models to Understand Human Conditions
Tidball, A. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816573-7.00002-x
Markouli, C., de Deckersberg, E. C., Dziedzicka, D., Regin, M., Franck, S., Keller, A., Gheldof, A., Geens, M., Sermon, K., & Spits, C. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.04.133496
Halliwell, J. A., Baker, D., Judge, K., Quail, M. A., Oliver, K. L., Betteridge, E., Skelton, J., Andrews, P. W., & Barbaric, I. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.11.198382
Du laboratoire à l’usage clinique : le défi de la production de plaquettes in vitro
Bouet, G., Mookerjee, S., Foster, H. R., Waller, A. K., & Ghevaert, C. (2020) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2020.10.004
Catelli, L. F., & Saad, S. T. O. (2021) · Stem Cells and Development · doi:10.1089/scd.2020.0185
CRISPR enriches for cells with mutations in a p53-related interactome, and this can be inhibitedPreprint
Jiang, L., Ingelshed, K., Shen, Y., Boddul, S. V., Iyer, V. S., Kasza, Z., Sedimbi, S. K., Lane, D. P., & Wermeling, F. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.10.434760
Lawrence, M., & Ghevaert, C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822230-0.00003-x
Genome editing for cellular disease modeling
Musunuru, K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823484-6.00002-5
Kim, Y., Go, Y., Jeong, H.-C., Kim, S., Cheong, H., Shin, H., Lee, H., & Cha, H.-J. (2021) · Research Square · doi:10.21203/rs.3.rs-626430/v1
Advances in generating HLA-Universal platelets for transfusion medicine
Lau, W. W. Y., & Ghevaert, C. (2021) · Journal of Immunology and Regenerative Medicine · doi:10.1016/j.regen.2021.100053
Skeletal muscle engineering using human induced pluripotent stem cells for in vitro disease modeling
Tey, S.-R., Robertson, S., & Suzuki, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823809-7.00006-2
Usher, I., Ligammari, L., Ahrabi, S., Hepburn, E., Connolly, C., Bond, G. L., Flanagan, A. M., & Cottone, L. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.12.467071
The Historical Origin and Significance of National Afro-American (Black) History Month Observance.
Young, A. H. (1980) · Negro history bulletin
Transplantation of human iPSC-derived kidney organoids
Kim, Y. K., & Freedman, B. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99892-5.00012-8
Rasmussen, R. A. (2017) · Applied Biosafety · doi:10.1177/1535676017715635
Jotzo, M., Zouboulis, C. C., & Ballhausen, W. G. (2022) · Die Ophthalmologie · doi:10.1007/s00347-022-01593-8
Stem cell therapy to treat macular degeneration
Abbasi, S., & Parmar, G. (2022) · University of Western Ontario Medical Journal · doi:10.5206/uwomj.v90i1.14008
Shay, J. W. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735914525.793561960
Abduljaleel, Z. (2022) · Research Square · doi:10.21203/rs.3.rs-2267701/v1
Towards functional kidney organoids
Schumacher, A. (2023) · doi:10.26481/dis.20230926as
Germ cell tumor treatment resistance and liquid biopsy-based microRNA biomarkers
Timmerman, D. M. (2024) · Utrecht University Repository (Utrecht University) · doi:10.33540/2055
Kim, Y.-J., Kim, S. M., Go, Y.-H., Kim, H. S., Park, S., Kang, Y. P., & Cha, H. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4786277
Dysregulation of immune tolerance to autologous iPSCs and their differentiated derivatives (review)
Bogomiakova, M. E., Bogomazova, A. N., & Lagarkova, M. A. (2024) · Biochemistry (Moscow) · doi:10.31857/s0320972524050036
Considerations in the development of pluripotent stem cell–based therapies
Cunningham, J. J., Capela, A., Priest, C. A., & Brandon, E. P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13344-2.00004-3
Immune and Mutational Profile of Gene-Edited Low-Immunogenic Human Primary Cholangiocyte OrganoidsPreprint
Petrus-Reurer, S., Baez‐Ortega, A., Lei, W., Kumaran, G. K., Williamson, J. C., Jones, J. L., Trajkovski, D., Lawson, A. R. J., Mahbubani, K. T. A., Brodie, C. R., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.20.628680
Nezhad, N. M., Rahimi, M., Gheybi, F., Kesharwani, P., Oroojalian, F., & Sahebkar, A. (2025) · Applied Materials Today · doi:10.1016/j.apmt.2025.102602 · Cited by 1
Blassberg, R. A., Mielczarek, O., Stombaugh, J., Okkenhaug, H., Torres, A. A., Russell, P., Lambourne, J. J., & Porreca, I. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.05.656583
徐, 慧. (2025) · Pharmacy Information · doi:10.12677/pi.2025.145037
REWRITE Enables Locus-Scale Engineering of Synthetic HLA Haplotypes in Human Pluripotent Stem CellsPreprint
Generoso, S., Levovitz, S., Jaramillo, S., Kim, M., Dara, S., Phen, S. F., Yi, B., Yanagi, T., DesMarais, T. L., Agmon, N., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.16.676382 · Cited by 1
Off-the-Shelf Engineered Liver Tissue Reverses Acute Liver Failure Without ImmunosuppressionPreprint
Raggi, C. C., Lapierre, P., M’Callum, M.-A., Pham, Q. T., Selleri, S., Paun, R. A., Baratang, N., Mangahas, C. L., Benabdallah, B., Moquin‐Beaudry, G., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.08.680796
Assou, S., Zenagui, R., Vincent, J., Manchon, L., & Vos, J. D. (2025) · Methods in molecular biology · doi:10.1007/978-1-0716-4767-7_9
Zhang, Q., Cui, L., Jia, Y., Shi, X., Zhang, J., Zhang, L., Liu, Z., Zhang, Y., Fu, H., Qi, Q., et al. (2025) · Stem Cells International · doi:10.1155/sci/3010753
Alsalloum, A., Mingaleva, N., Gornostal, E. A., Antysheva, Z., Sparber, P. A., Skoblov, M. Y., Pozhitnova, V. O., Белышева, Т. С., Levashova, A., Kuznetsova, E., et al. (2025) · Cells · doi:10.3390/cells14241985
Bi, C., Wang, L., Yuan, B., Zhou, X., Li, Y., Wang, S., Pang, Y., Gao, X., Huang, Y., & Li, M. (2020) · Figshare · doi:10.6084/m9.figshare.12858515
Bi, C., Wang, L., Yuan, B., Zhou, X., Li, Y., Wang, S., Pang, Y., Gao, X., Huang, Y., & Li, M. (2020) · Figshare · doi:10.6084/m9.figshare.12858518
Kim, J.-H., Kurtz, A., Barbaric, I., Inamdar, M. S., Pera, M. F., Benvenisty, N., Shakiba, N., Isasi, R. M., Hanatani, T., & Stacey, G. N. (2026) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04797-2
Self-citationLee, S. W., Kim, Y.-J., Kang, S., Cha, H., & Kim, H. J. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.174074
Dong, S., Xing, X., Čechová, M., Loucks, H., Vijayalingam, S., Neilson, A., Sentmanat, M. F., Macias-Velasco, J. F., Liu, T. C., Dong, Z., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.14.705860
The challenges of choosing your pluripotent stem cell line
Barker, R. A., & Kirkeby, A. (2026) · Stem Cell Reports · doi:10.1016/j.stemcr.2026.102864
Maurinot, F. (2019) · theses.fr (ABES) · doi:10.70675/f15d5957z45d3z4384zb0dbze345ee20e930
Arduini, B. L., Blenkinsop, T. A., Naimark, M., Borden, S. M., Charniga, C. J., Campbell, M., Rugenstein, N., Davis, R. J., Alam, N. M., Prusky, G. T., et al. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.102779
Qi, L., Bertucci, T. B., Borden, S. M., Arduini, B. L., Lotz, S., Bowles, K. R., Goate, A., Karch, C. M. M., Temple, S., & Geschwind, D. H. (2026) · SSRN Electronic Journal · doi:10.64898/2026.04.29.721747
Zhang, M., Hu, C., Liu, H., Zhang, C., Shu, Q., Kang, Y.-J., Ding, Y., Zhang, J., Hu, Z., Wang, H., et al. (2026) · Oncogene · doi:10.1038/s41388-026-03824-7
Sozza, F., Romano, A., D'Elia, N., Terenzi, M., Ratto, M. L., Cliff, E. R., Nattenberg, G., Bianchi, S. D., Becca, S., Klug, H., et al. (2026) · SSRN Electronic Journal · doi:10.2139/ssrn.6885667 · Cited by 1
Genomic stability of human pluripotent stem cells: advances in research and screening criteria
Li, C., Long, M., Xiang, L., Ai, Z., & Yin, Y. (2026) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szag040
Qin, Y., Guo, S., Chen, W., Ji, X., Liu, J., & Zheng, H. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1877664
Kawaguchi, H. (2026) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2026.2710868
From Gene Editing to Exogenesis: Pigs as a Source of Immune-compatible Organs for Transplantation
Ali, A., Kurome, M., Reichart, D., Reichart, B., Garry, M. G., Masaki, H., Nakauchi, H., Sachs, D. H., Garry, D. J., & Wolf, E. (2026) · Transplantation · doi:10.1097/tp.0000000000005845
Krupalnik, V., Kawamata, S., Mountford, J. C., Muschler, G. F., Bando, H., Cui, W., Zhang, X., Ludwig, T. E., Munsie, L., Agabalyan, N. A., et al. (2026) · Cytotherapy · doi:10.1016/j.jcyt.2026.102969
The evolution of iPSC-based cell therapy across autologous and allogeneic pathways
Wang, A., Zhang, Y., Deng, H., & Gu, M. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.102992
How Does Genetic Drift Impact the Safety of Cell-Cultivated Products?
Food Standards Agency, Romero, R., Walshaw, J., Winter, M., & Kitson, J. (2026) · FSA research and evidence. · doi:10.46756/001c.165033
Induced pluripotent stem cells from discovery to translation
Lee, J., Herron, T. J., Studer, L., Mummery, C. L., & Wu, J. C. (2026) · Nature Medicine · doi:10.1038/s41591-026-04584-3 · Cited by 2
Bratt‐Leal, A. M., Gorba, T., Williams, R. M., Mossman, J. A., Hills, R., Tran, H., Barken, D. M., Beauvais, G., Fremgen, D. M., Zhang, A., et al. (2026) · Cell stem cell · doi:10.1016/j.stem.2026.08.014
Cha, Y., & Kim, K. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.103104
Khan, I., Rungsiwiwut, R., Thongphakdee, A., Subboriboon, S., Angchuan, C., Samruan, W., Khalil, A. A. K., & Parnpai, R. (2026) · Biology · doi:10.3390/biology15201833
Metadata
- Authors
- Merkle, F. T., Ghosh, S., Kamitaki, N., Mitchell, J., Avior, Y., Mello, C., Kashin, S., Mekhoubad, S., Ilic, D., Charlton, M., Saphier, G., Handsaker, R. E., Genovese, G., Bar, S., Benvenisty, N., McCarroll, S. A., & Eggan, K.
- Affiliations
- Broad Institute (US)
- Hebrew University of Jerusalem (IL)
- Harvard University (US)
- Corresponding author
- McCarroll, Steven A.
- Eggan, Kevin
- ORCID
- Venue
- Nature
- Published
- 2017-04-26
- Volume
- 545
- Issue
- 7653
- Pages
- 229-233
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC5427175
- OpenAlex
- W2608500349
- Cited by
- 506
- References
- 44
- Citations by year
- 2026: 38 · 2025: 44 · 2024: 50 · 2023: 42 · 2022: 56 · 2021: 68 · 2020: 65 · 2019: 54 · 2018: 50 · 2017: 35
- FWCI
- 22.89
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Apollo
- Funders
- Wellcome Trust
- Academy of Medical Sciences (SBF001\1016)
- Rosetrees Trust (M108-F1)
- National Institutes of Health (5K99NS08371)
- Medical Research Council (MC_PC_12009, MR/P501967/1)
- National Heart, Lung, and Blood Institute (R01HL109525)
- National Human Genome Research Institute (R01HG006855)
- National Institute of General Medical Sciences (P01GM099117)
- National Institute of Neurological Disorders and Stroke (K99NS083713)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Keywords
- human pluripotent stem cells, human embryonic stem cells, induced pluripotent stem cells, TP53 mutation, dominant-negative p53, somatic mosaicism, copy number variation, clonal expansion, tumour suppressor, DNA-binding domain, stem cell culture conditions, exome sequencing, RNA sequencing
- MeSH terms
- Human Embryonic Stem Cells, Protein Domains, Alleles, Cell Count, Cell Differentiation, Cell Division, Cell Line, DNA, DNA Mutational Analysis, Genes, Dominant, Humans, Mosaicism, Mutation, Neoplasms, Selection, Genetic, Genes, p53, Tumor Suppressor Protein p53, Loss of Heterozygosity, Induced Pluripotent Stem Cells, Exome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
